An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Insight Partners with Global Nonprofit Vivli on First-Ever Industry Antimicrobial Resistance Research Platform
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
partnership
Rhea-AI Summary
Insight Enterprises (NASDAQ:NSIT) has collaborated with Vivli to launch the Antimicrobial Resistance Register, a global platform aimed at combating antimicrobial resistance. This initiative facilitates data sharing among biopharmaceutical companies regarding infection-causing pathogens, crucial for identifying resistance trends and fostering drug innovation. Vivli's Executive Director emphasized the platform's role in combating a significant global health threat. The AMR Register is supported by a renowned Scientific Advisory Board and was initiated with funding from the Wellcome Trust.
Positive
Launch of the Antimicrobial Resistance Register enhances data sharing on infection-causing pathogens.
Addresses critical global health threats posed by antimicrobial resistance.
Facilitates innovation in new antimicrobial drugs and informs policy on antibiotic stewardship.
Support from Wellcome Trust provides credibility and initial funding.
Negative
None.
Clinical research initiative combats global threats to public health by accelerating data sharing on infection-causing pathogens and antibiotic resistance
CHANDLER, Ariz.--(BUSINESS WIRE)--
Insight Enterprises (NASDAQ:NSIT), a Fortune 500 solutions integrator helping clients accelerate their digital journey, announced today that it has worked with Vivli, a nonprofit dedicated to advancing human health through clinical research data sharing, to support the launch of Vivli’s Antimicrobial Resistance Register (AMR Register). The revolutionary, global platform allows biopharmaceutical companies to share susceptibility data on infection-causing pathogens.
“The launch of the AMR Register platform marks a critical step in combating the growing global health threat of antimicrobial resistance, in which illnesses that were once easily treatable with antibiotics are becoming more difficult to cure,” said Vivli Executive Director Rebecca Li, PhD. “The support of Insight’s technology solutions and deep technical expertise was integral in Vivli’s efforts building the AMR Register, which can help researchers securely access critical raw data, combine and analyze multiple datasets from across the industry, contain the risk of antimicrobial resistance and, ultimately, advance scientific knowledge.”
The launch of Vivli’s AMR Register is the first single, streamlined online platform to promote open sharing of industry surveillance data and will support researchers in their efforts to:
Identify global, regional and local changes in resistance rates of pathogens;
Detect trends in multi-drug resistance by analyzing data over time and enable modelling of future resistance trends;
Catalyze innovation around new antimicrobial drugs; and
Help inform national and international policy and antibiotic stewardship.
“Research insights that are informed by reliable, robust data ecosystems are hugely important across the healthcare industry, as well as pharmaceutical and biotech enterprises, who are working to control antimicrobial resistant infections and protect human health,” said Stan Lequin, senior vice president and general manager, Solutions, Insight. “Innovation like the AMR Register fills that gap in data translation and can spur meaningful action that has the potential to save lives as Vivli works to curtail one of the top global public health threats. We are proud to support Vivli’s work and vision preserving antibiotics for — and protecting the health of — future generations worldwide.”
Insight has been the nonprofit’s long-standing technical development and platform maintenance partner, supporting Vivli’s launch of its Covid-19 data sharing portal in April 2020 and its global clinical trial research platform in 2018.
The AMR Register is guided by a Scientific Advisory Board of influential leaders in antimicrobial resistance and global health, including Henry Kajumbula, MD of Makerere University College of Health Sciences; Trudie Lang of the Nuffield Department of Medicine; Marc Mendelson, PhD, of Groote Schuur Hospital, University of Cape Town; Arjun Srinivasan, MD, from the Centers for Disease Control and Prevention; Janet Midega, PhD, from Wellcome; and Andy Stergachis, PhD, of the University of Washington. The AMR Register was made possible with an initial seed grant from the Wellcome Trust.
For more information on Vivli’s AMR Register, visit amr.vivli.org.
For more information on Insight, visit insight.com or call 800-INSIGHT.
About Insight
Insight Enterprises, Inc. is a Fortune 500 solutions integrator with more than 11,500 teammates worldwide helping organizations accelerate their digital journey to modernize their business and maximize the value of technology. We enable secure, end-to-end transformation and meet the needs of our clients through a comprehensive portfolio of solutions, far-reaching partnerships and 33+ years of broad IT expertise. Rated as a Forbes World’s Best Employer and a Great Place to Work, we amplify our solutions and services with global scale, local expertise and a world-class e-commerce experience, realizing the digital ambitions of our clients at every opportunity. Discover more at insight.com. NSIT-M
About Vivli
Vivli is a nonprofit organization working to advance human health through the insights and discoveries gained by sharing and analyzing data. Data sharing initiatives include the Antimicrobial Resistance Registerfor AMR surveillance data and theVivli Platformfor clinical trial data. Vivli acts as a neutral broker between data contributor and data user and the wider data sharing community. For more information, visitwww.vivli.organd follow us on Twitter@VivliCenter.
